We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$3.54B
AUM Growth
-$241M
Cap. Flow
-$381M
Cap. Flow %
-10.76%
Top 10 Hldgs %
60.83%
Holding
90
New
24
Increased
12
Reduced
37
Closed
15

Sector Composition

Rank Sector Weight
1 Financials 27.68%
2 Technology 15.65%
3 Consumer Discretionary 8.82%
4 Communication Services 7.32%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHK icon
51
Mohawk Industries
MHK
$7.5B
$8.27M 0.23%
38,605
-6,995
-15% -$1.53M
XOM icon
52
ExxonMobil
XOM
$644B
$7.02M 0.2%
84,835
-5,490
-6% -$437K
TSLA icon
53
Tesla
TSLA
$1.23T
$6.86M 0.19%
+300,000
New +$6.1M
BKI
54
DELISTED
Black Knight, Inc. Common Stock
BKI
$6.75M 0.19%
126,061
-12,757
-9% -$642K
BMRN icon
55
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.15M 0.17%
+65,300
New +$5.72M
CPB icon
56
Campbell Soup
CPB
$6.55B
$5.75M 0.16%
+141,850
New +$5.52M
BLUE
57
DELISTED
bluebird bio
BLUE
$5.28M 0.15%
+2,597
New +$5.92M
ONCE
58
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$5.25M 0.15%
+63,400
New +$4.89M
F icon
59
Ford
F
$58.5B
$5.14M 0.15%
464,310
-52,990
-10% -$607K
HA
60
DELISTED
Hawaiian Holdings, Inc.
HA
$5.1M 0.14%
141,859
-108,141
-43% -$4.17M
ABEO icon
61
Abeona Therapeutics
ABEO
$366M
$4.45M 0.13%
+11,120
New +$4.86M
CLLS
62
Cellectis
CLLS
$277M
$4.34M 0.12%
+153,559
New +$4.57M
QURE icon
63
uniQure
QURE
$3.03B
$4.29M 0.12%
+113,500
New +$3.63M
WVE icon
64
Wave Life Sciences
WVE
$1.09B
$4.28M 0.12%
+112,000
New +$4.82M
RARE icon
65
Ultragenyx Pharmaceutical
RARE
$2.45B
$4.16M 0.12%
+54,100
New +$3.49M
CVNA icon
66
Carvana
CVNA
$68.6B
$3.74M 0.11%
+450,000
New +$2.71M
RGNX icon
67
CALL
Regenxbio
RGNX
$620M
$3.59M 0.1%
+50,000
New +$2.39M
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
$3.52M 0.1%
+296,783
New +$3.7M
AUD
69
DELISTED
Audacy, Inc.
AUD
$3.47M 0.1%
459,188
+74,344
+19% +$630K
SGMO
70
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.45M 0.1%
+243,000
New +$4.04M
CRSP icon
71
CRISPR Therapeutics
CRSP
$4.73B
$3.35M 0.09%
+57,000
New +$3.25M
NTLA icon
72
Intellia Therapeutics
NTLA
$1.49B
$3.28M 0.09%
+120,000
New +$2.91M
EDIT icon
73
Editas Medicine
EDIT
$396M
$3.11M 0.09%
+86,765
New +$3.07M
SLDB icon
74
Solid Biosciences
SLDB
$794M
$2.84M 0.08%
+5,313
New +$1.63M
GG
75
DELISTED
Goldcorp Inc
GG
$1.9M 0.05%
138,505
-12,395
-8% -$172K

Similar funds

WS Management's Q2 2018 Portfolio in Review

As of Q2 2018, WS Management held 90 positions worth $3.54B, down 6.4% from $3.79B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

WS Management withdrew a net $381M in Q2 2018, closing 15 positions and reducing 37 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, WS Management opened a new position in ScottsMiracle-Gro worth $15.7M.

  • WS Management's largest Q2 2018 buy was ScottsMiracle-Gro: 189,224 shares worth $15.7M.
  • WS Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $138M increase.
  • WS Management's biggest Q2 2018 reduction was Micron Technology, cutting an estimated $226M.
  • WS Management fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $100M.
  • WS Management's ten largest holdings make up 61% of its $3.54B portfolio in Q2 2018.
  • WS Management opened 24 new positions and closed 15 in Q2 2018.
  • WS Management's portfolio value fell 6.4% quarter-over-quarter to $3.54B.

Based on WS Management's 13F filing for Q2 2018, filed 13 Aug 2018.